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A total of 52 strains of Pseudomonas identified as P. aeruginosa (27), P. putida (9), P. fluorescens (13) 
and P. stutzeri (3) were isolated from Nigerian patients with burns, wound and skin infections, UTI, 
diarrhoea and eye infections.  81.5, 55.6, 76.9 and 33.3% of these species produced pyocins at a range 
of 410 – 670 g/ml.  High yields of pyocins at 35 – 37oC, which declined sharply at temperatures above 
37oC were obtained from all the producing strains.  The strains also displayed significant pyocin 
expression (P < 0.05) under UV irradiation. Pyocins from a total of 25 producing strains; P. aeruginosa 
(14/27), P. putida (4/9), P. fluorescens (7/13) were inhibitory to the growth of P. putida indicator strain 
with four strains: PA02, PA20, PP03 and PF01 producing inhibition zone diameter >3 mm.  These 
pyocins also displayed growth inhibitory activity against some Nigerian isolates of Gram-positive and 
Gram-negative bacteria when undiluted and at 1:2 - 1:16 dilutions.  The susceptible organisms include 
Bacillus cereus, Listeria monocytogenes, Klebsiella spp., Staphylococcus aureus, S. epidermidis, 
Proteus spp. and Vibrio parahaemolyticus. The results of this study have provided evidence for broad-
spectrum antibacterial activity of pyocins elicited by Pseudomonas species from Nigeria. 
 





Human Pseudomonas species, with preference for moist 
body sites have been recognized to cause infections of 
high morbidity and mortality by virtue of several virulence 
factors that they express (Pollack, 1994). These factors 
include endotoxins, which mediate the pathogenesis of 
bacteremia and sepsis, exotoxin A, which arrests protein 
synthesis in the host cell (Klinger et al., 1978) and 
pyocins, which are pigments of many uses (Vanloon et 
al., 1998; Padilla et al., 1992).  Parret and De Mot (2001) 
demonstrated the pyocins of non-fluorescent 
Pseudomonads as plant growth promoting substances 
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population dynamics of isolates colonizing the rhizosp-
heres of crops. Furthermore, pyocin-based coliform 
detecting systems have been developed as an assessor 
of microbial quality of water samples and foods (Betts et 
al., 1993), while the antibacterial property of these 
pigments is highly varied and seems to know no bounds 
(Hassan and Fridovitch, 1980; Duncan et al., 1997).  It 
has been reported that 25 out of the over 140 species of 
Pseudomonas infect man and the pre-eminence of these 
species as etiological agents of bacteremia and sepsis as 
well as other opportunistic infections is grossly heteroge-
neous (Woods and Iglewski, 1983).  In Nigeria, little work 
has been done on Pseudomonas spp. To the best of our 
knowledge, there is virtually no report on species 
production of pyocins as documented elsewhere and the 






Scientific opinions on a global scale are yet to succumb 
to the need of refining pyocins for commercial antibacte-
rial use. However, to strengthen the consideration of an 
industrial pyocin for use as antibacterial agents, it is 
essential that reports concerning antibacterial properties 
of pyocins and factors influencing pigment yields by 
isolates from Africa, other developing and underdeve-
loped countries are furnished and updated. In the present 
study, clinical isolates of Pseudomonas species were 
recruited and the antibacterial activity of pyocins from 
producing strains against Gram-positive and Gram-
negative bacteria was studied.  We also investigated the 








A total of fifty-two Pseudomonas isolates were obtained from thirty-
three (33) in-patients and nineteen (19) outpatients at the General 
and Teaching hospitals in Lagos, Nigeria.  The patients were 
diagnosed and being treated for urinary tract infections, wound 
infections, septicaemia, ear infection and eye infections. The 
isolates were identified based on growth on Pseudomonas agar 
supplemented with cetrimide and sodium nalidixate (Oxoid, 
England) and further biochemical differentiation according to 
Weyant et al. (1995). The speciated isolates were studied for 
antibacterial activity of the pyocin that they expressed. The effects 
of temperature and ultraviolet radiation on pyocin production in 
these isolates were also investigated. The pure isolates were used 
immediately for pyocin analysis.  
 
 
Pyocin yield and selection of producing strains 
 
Five distinct colonies of each Pseudomonas strain on 
Pseudomonas agar were subcultured in 5 ml of tryptic soy broth.  
The inoculated broths were then incubated aerobically at 37oC for 
24 h. Pyocin producing strains were selected as those that yielded 
yellow, yellowish brown, green or greenish blue pigmentation after 
incubation. The method of Rogers (1973) was used for pyocin 
quantitation.  Briefly, pyocin producing strains were grown 
aerobically overnight at 37oC with shaking (120 rpm) in Tris-minimal 
succinate solution without iron and glucose but containing MgCl2 
(500 µM), CaCl2 (100 µM) and methionine (700 µM). The resulting 
cultures were then centrifuged at 4000 rpm for 10 min and 
supernatant acidified with ethyl acetate in 5:2 volume ratio. The 
acidified pyocin fraction was then concentrated under reduced 
pressure using a rotary evaporator at 50oC.  The crude pyocin 
preparation obtained was then dissolved in 400 µl sterile water, 
sterilized by passage through a 0.45 µM filtration unit and the yield 
measured in µg/ml.  A non-pyocin strain of Pseudomonas putida 
PUC 34 was used as control. 
 
 
Effect of temperature on pyocin production 
 
The pyocins producing Pseudomonas strains studied were selected 
and further incubated aerobically in tryptic soy broth at 20, 25, 30, 
37, 40 and 42oC.  The yields of pyocins produced were determined 
as described earlier. A sterile broth solution was used as a negative 
control. The turbidity of the broth culture was first adjusted to 0.5 
McFarland standard (108 cfu/ml) and finally to an inoculum size of 5 




x 105 cfu/ml using sterile broth. 
 
 
Effect of ultra violet radiation 
 
Four young cultures of each of the pyocin producing species were 
grown for 16 h at 35oC under ultra violet light.  As a measure of 
comparison of pyocin yield, cultures were also grown in tryptic soy 
broth for 16 h but in the absence of ultraviolet irradiation. Cultures 
were irradiated at a distance of 30 cm from the UV transilluminator 
(Memmer, Germany). The amounts of pyocin expressed were 
determined and compared. 
 
 
Preliminary antibacterial testing of pyocins 
 
The initial antibacterial testing of pyocin was carried out using the 
double agar diffusion method as described by Parret and De Mot 
(2000).  An inoculum of size 108 cfu/ml of each of the pyocin 
producing strains was used to inoculate nutrient agar followed by 
incubation at 35oC for 8 h.  The resultant colony was then killed by 
flooding with 10 ml of chloroform for 30 min.  Thereafter, chloroform 
was removed by plate inversion and evaporation in open air.  One 
ml of P. putida indicator strain 15070 culture (108 cfu/ml) in tryptic 
soy broth was mixed with 12 ml of molten soft agar (0.8%) and used 
to overlay the plate.  The plate was further incubated aerobically at 
35oC for 24 h.  The bacteriocinogenicity of the pyocin tested was 
defined as the appearance of clear zone of no bacterial growth 
around the colonies.  A non-pyocin producing strain of P. putida 
was used a negative control. 
 
 
Measurement of bacteriocinogenicity of Pseudomonas pyocins 
 
On species basis, each pyocin producing strain was subcultured 
into tryptic soy broth in quadruple and pyocin was extracted after 24 
h of incubation. The extracted pyocins were pooled together and 
each pool was diluted 1:2, 1:4, 1:8, 1:16, 1:32, 1:64 and 1:128 with 
tryptic soy broth. The antibacterial activity of these dilutions was 
subsequently tested on the following isolates: Bacillus cereus, B. 
licheniformis, B. subtilis, Listeria monocytogenes, Clostridium 
difficile, Staphylococcus aureus, S. epidermidis, Esherichia coli, 
Klebsiella spp., Salmonella typhi, Proteus spp., Vibrio 
parahaemolyticus, Shigella flexneri and S. dysenteriae. The 
organisms were local isolates recovered from diarrhoeal stools, 
urine, swabs and food samples at the Genetics and Microbiology 
laboratory of the National Institute for Medical Research, (N.I.M.R.) 
Nigeria. Minimum inhibitory dilution of pyocin produced by 
Pseudomonas against the local strains tested was defined as the 





The parameters obtained as pyocin yields were expressed as mean 
± standard deviation from mean. The difference between values 
was analyzed using the Student’s t - test and at 95% confidence 





The origins of fifty-two Pseudomonas species studied for 
pyocin production and bacteriocinogenicity are 
summarized in Table 1. Four species of Pseudomonas 
were  identified  biochemically   from   patients   with   eye  




Table 1. Sources of the Pseudomonas strains tested for pyocin production and 
antibacterial activity against microorganisms including an indicator strain of 
Pseudomonas putida.  
 
Infection                                                            Isolates  ( N ) 
Skin infection                                            Pseudomonas aeruginosa (8) 
Skin infection                                            Pseudomonas fluorescens (4) 
 Skin infection                                            Pseudomonas putida (2) 
Wound infection                                        Pseudomonas aeruginosa (7) 
Wound infection                                        Pseudomonas putida (4) 
Wound infection                                        Pseudomonas fluorescens (2) 
Burns Pseudomonas aeruginosa (3) 
Burns Pseudomonas fluorescens (7) 
Burns Pseudomonas putida (2) 
Burns Pseudomonas stutzeri (2) 
Ear infection                                               Pseudomonas aeruginosa (2) 
Ear infection                                    Pseudomonas putida (1) 
Ear infection                                               Pseudomonas stutzeri (1) 
Urinary tract infection (UTI)                      Pseudomonas aeruginosa (4) 
Urinary tract infection (UTI)                      Pseudomonas putida (2) 
Eye infection                                               Pseudomonas aeruginosa (2) 
Septicaemia      Pseudomonas aeruginosa (2) 
 




Table 2. Pyocin production among the Pseudomonas isolates. 
 
Pseudomonas species (N) Pyocin producers  n (%) Pyocinyield   (g/ml) 
Pseudomonas aeruginosa)                                     22 (81.5) 600 
P. putida (9)                                                    5 (55.6) 670 
P. fluorescens (13)                                                               10 (76.9) 640 
P.stutzeri (3)    1 (33.3) 410 
 































Figure 1. Effect of temperature on pyocin production. Projections 
on data points represent standard deviations of mean pyocin yield. 
infection, diarrhoea, ear infection, burns, wound and skin 
infections.  The isolates were P. aeruginosa (27 strains), 
P. putida (9 strains), P. fluorescens (13 strains) and P. 
stutzeri (3 strains) (Table 1).  22 of the 27 P. aeruginosa 
strains, 5 of 9 P. putida, 10 of 13 P. fluorescens and 1 of 
3 P. stutzeri strains expressed pyocins at a yield range of 
410 – 670 µg/ml.  The 81.5 and 33.3% of P. aeruginosa 
and P. stutzeri corresponded to the highest and lowest 
producers of pyocin s among the strains tested (Table 2).  
Pyocin production increased with temperature up to 37oC 
in all the pyocin producers tested.  However, at above 
37oC, pyocin production declined sharply in all the 
strains. Only P. aeruginosa produced little pyocin at 42oC 
(Figure 1). The higher pyocin production in P. aeruginosa 
(1400 vs. 1025 µg/ml), P. putida (1225 vs. 862.5 µg/ml) 
and P. fluorescens (1375 vs. 1012.5 µg/ml) were 
expressed under UV irradiation.  These increases were 
found to be  significant  (P < 0.05)  when  compared  with 




Table 3. A comparative study of the effect of ultraviolet radiation on pyocin production among the 
Pseudomonas isolates. 
 
Pyocin yield ± SD µg/ml)  
P. aeruginosa P. putida P. fluorescens 
+UV Light            1400 + 182.6a 1225 ± 170. 6a 1375 ± 179.2a 
-UV Light            1025 ± 64.5 862.5 ± 149.3 1012.5 ± 131.5 
                                




Table 4.  Bacteriocinogenicity of Pseudomonas 
isolates against indicator strains. 
 
Inhibition zone diameter (IZD) in millimeters 
(mm) of the tested strains. 
+ ++ +++ 
PA01 PA05 PF01 
PP02 PP05 PA02 
PP04 PF08 PP03 
PF04 PF09 PA20 
PF05 PA11  
PA07 PA17  
PA08   
PA10   
PF11   
PA12   
PF12   
PA15   
PA18   
PA19   
PA22   
 
Symbols: +, Inhibition zone diameter (IZD) ≤ 1mm; ++, 
IZD 1 - 3mm; +++, IZD > 3mm. Strains: PA, 
Pseudomonas aeruginosa; PP, Pseudomonas putida; 




pyocin expression in the absence of UV light in these 
strains  (Table 3). The data presented in Table 4 shows 
that, 14 of  the 22  pyocin  strains  of P. aeruginosa and 7 
of 10 P. fluorescens were inhibitory to the growth of the 
indicator strain (P. putida 15070), producing inhibition 
zone diameter (IZD) mostly in the range of 1 – 3 mm.  
Four of the P. putida pyocin strains gave similar result.  
IZD > 3 mm was produced by pyocins of four strains of 
Pseudomonas tested; PA02, PA20, PP03 and PF01.  
The pyocins also elicited antibacterial activity against 
some Nigerian isolates of Gram-positive and Gram-
negative bacteria at different dilutions. For instance, the 
growth of B. cereus, Clostridium difficile and Klebsiella 
spp was inhibited by undiluted pyocins from P. 
aeruginosa, P. putida and P. fluorescens, while B. 
subtilis, Staphylococcus aureus, E. coli and Salmonella 
typhi were inhibited at 1:2 – 1:16 dilutions (Table 5).  
DISCUSSION 
 
Pseudomonas  species  have  on  many  occasions  been  
reported as major etiological agents of nosocomial 
infections and as pathogens predominantly isolated in 
burns and wounds in Nigeria (Atoyeba et al., 1982; Egri-
Okwaji et al., 1988). The prevalence of pyocin producing 
P. aeruginosa as obtained in this study may not be 
unconnected with the virulence of potential of pyocin in 
causing diseases (Wood and Iglewski, 1983).  Some of 
the Pseudomonas strains were observed not to produce 
these pigments and this indicates the co-existence of 
pyocin and non-pyocin strains in bacterial population of 
Pseudomonads. Our observation supports the work of 
Parret and De Mot (2001) where important functional 
roles were ascribed to the non-pyocin producing strains 
of P. putida in the ecology of microbes colonizing the 
rhizospheres of crops.  We also observed that these 
pyocins were differently expressed among the producing 
strains and this implies variation in pyocin expression 
among the strains.  Differences in promoter-mediated 
transcription of pyocin gene or whether expression is 
inducible or constitutive cannot be ruled out. This is 
because for instance, expression of three different types 
of pyocins: S, F, and R have been demonstrated in P. 
aeruginosa and in a separate study these pyocins were 
shown to bear genetic relatedness to different phages 
(Keisuke et al., 2001). Matsui et al. (1993) had earlier 
noted that the regulation of bacteriocins in bacteria is 
under SOS control. The functional domains of most 
pyocins could also be the basis for their varied 
expressions as these functions may determine the 
mechanism of virulence amongst Pseudomonas (Sano et 
al., 1993).  
The expression of pyocins by the producing strains was  
also observed to increase with temperature up to 37oC 
and declined sharply at temperatures above 37oC.  
Maximum colonial growth of all the organisms was 
observed at 35-37oC (results not shown). This may mean 
that pyocin production is linked to the growth of the 
organisms. However, only P. aeruginosa strains 
elaborated little pyocins at 42oC and this may be because 
the organism readily demonstrates growth at this 
temperature (Pollack, 1994). The role played by 
ultraviolet light in the expression of bacteriocins by 
microorganisms  has  also  been well documented. Braun  




Table 5. The determination of minimum inhibitory dilution of pyocins of Pseudomonas species against test organisms.  
 
Minimum inhibitory dilution (MID) of pyocins Test organisms 
P. aeruginosa P. putida P. fluorescens 
Bacillus cereus 1:2 Undiluted Undiluted 
B. subtilis 1:2 1:2 1:2 
Clostridium difficile              Undiluted ND Undiluted 
Listeria monocytogenes Undiluted ND 1:2 
Staphylococcus aureus 1:4 1:2 Undiluted 
S. epidermidis 1:8 1:2 Undiluted 
Escherichia coli 1:8 1:8 1:4 
Salmonella typhi. 1:16 Undiluted 1:8 
Klebsiella spp.                          1:4 1:2 Undiluted 
Proteus spp.                          Undiluted ND 1:2 
Vibrio parahaemolyticus          1:4 1:2 1:8 
Shigella flexneri                    Undiluted Undiluted ND 
Shigella dysenteriae                  ND ND ND 
 




et al. (1994) demonstrated the induction of bacteriocins 
production in E. coli by UV irradiation, while in the works 
of Sano et al. (1993) and Duport et al. (1995), s-type 
pyocin production in P. aeruginosa strains under UV 
stimulation was clearly shown. In this study, a significant 
increase (P < 0.05) in pyocin expression was observed in 
all the production strains when grown in the presence of 
ultraviolet light. This result connotes the inducibility of 
pyocin genes in Pseudomonads and further attests to 
previous findings (Sano et al., 1993; Duport et al., 1995). 
Although, molecular weight characterization of pyocins 
was not carried out in this study, it will be of interest with 
regards to pyocin induction to note that a bacteriocins-like 
protein with a molecular weight of approximately 14 kDa 
has been isolated from Pseudomonas spp. BMW11M1 
strain under UV stress (Parret and De Mot, 2001).  
Pyocins have also been found to be active against 
closely related species or strains (Ryder and McClure, 
1997). That some of the pyocins isolated in this study 
inhibited P. putida 15070 indicator strain is supportive of 
the work of Parret and De Mot (2001) where crop 
colonized pyocin-producing Pseudomonas strains 
inhibited P. fluorescence indicator strains and P. putida 
15070.  However, the inability of some of the isolated 
pyocins to inhibit P. putida 15070 further reflects the 
variations inherent in the functions of pyocins.  Pyocins 
have been found to function as tRNase, pore formers and 
DNase (Parret and De Mot, 2000; Sano, 1993). This 
study also reveals the broad-spectrum antibacterial 
activity of the pyocins of Pseudomonas species from 
Nigeria. Soil bacteria such as Bacillus subtilis and B. 
cereus were found to be susceptible to pyocins (Parret 
and De Mot, 2001; Petrocheilou-Malleiru et al., 1987). In 
addition some organisms of epidemiological and clinical 
importance in Nigeria were also inhibited. These 
organisms include such as Shigella flexneri (Iwalokun et 
al., 2001), Staphylococcus aureus (Olukoya et al., 1995) 
and Salmonella typhi (Akinyemi et al., 2000).  
It can be concluded that Pseudomonas isolates from 
Nigeria produce pyocins with broad-spectrum 
antibacterial activity and whose production is accelerated 
under UV stress. Further work on molecular 
characterization of pyocins will be carried out and new 
microorganisms will be tested for bacteriocinogenicity in 
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